Over 115 companies located in various regions across the globe claim to provide contract fill
Despite the fact thatbiopharmaceuticals offer significant profit margins, innovator companies areplagued by high costs of development, complex production protocols and specialprocedures and equipment for fill / finish operations. Consequently, a numberof drug manufacturers have demonstrated a preference for outsourcing fill /finish operations of such products.
To order this 480+page report, which features 350+ figures and 260+ tables, please visit this link
The USD 4.2 billion(by 2030) financial opportunity within the biologics fill / finish services markethas been analyzed across the following segments:
§ Types of Primary Packaging Containers
§ Ampoules
§ Cartridges
§ Syringes
§ Vials
§ Types of Biologics
§ Peptides / proteins
§ Antibodies
§ Vaccines
§ Cell therapies
§ Gene therapies
§ Viral products
§ Oligonucleotides
§ Others
§ Company Size
§ Small-sized
§ Mid-sized
§ Large / very large
§ Scale of Operation
§ Preclinical
§ Clinical
§ Commercial
§ Key Therapeutic Areas
§ Cancer
§ Infectious diseases
§ Autoimmune diseases
§ Cardiovascular diseases
§ Other indications
§ Key Geographical Regions
§ North America (US, Canada)
§ Europe (UK, France, Germany, Italy, Spain and rest of theEurope)
§ Asia-Pacific (Japan, China, South Korea, India and Australia)
The BiologicsFill / Finish Services Market, 2020-2030 report features thefollowing companies, which we identified to be key players in this domain:
§ Advanced BioScience Laboratories(ABL)
§ Albany Molecular Research (AMRI)
§ Biocon
§ BioPharma Solutions
§ BioReliance
§ Boehringer IngelheimBioXcellence
§ ChemPartner
§ Emergent BioSolutions
§ IDT Biologika
§ Lonza
§ LuinaBio
§ Mycenax Biotech
§ Patheon
§ Recipharm
§ Vetter Pharma
§ WuXi Biologics
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Competitive Landscape
5. Company Competitiveness Analysis
6. Biologics Fill / Finish Service Providers inNorth America: Company Profiles
7. Biologics Fill / Finish Service Providers inEurope: Company Profiles
8. Biologics Fill / Finish Service Providers inAsia-Pacific: Company Profiles
9. Partnerships and Collaborations
10. Recent Expansions
11. Capacity Analysis
12. Demand Analysis
13. Biologics Manufacturing and Fill / Finish:Key Performance Indicator Analysis
14. Market Sizing and Opportunity Analysis
15. Future Growth Opportunities
16. Case Study: Robotic Systems in Fill /Finish Operations
17. Case Study: Ready-to-Use PackagingComponents in Aseptic Fill / Finish Operations
18. Conclusion
19. Interview Transcripts
20. Appendix 1: Tabulated Data
21. Appendix 2: List of Companies andOrganizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
